Related Experiment Video
Updated: Jul 10, 2026

08:30
Neonatal Murine Cochlear Explant Technique as an In Vitro Screening Tool in Hearing Research
Published on: June 8, 2017
Application of deafness diagnostic screening panel based on deafness mutation/gene database using invader assay
Satoko Abe1, Toshikazu Yamaguchi, Shin-Ichi Usami
1Division of Advanced Technology and Development, BML, Inc., Kawagoe-shi, Saitama 350-1101, Japan.
Genetic Testing
|October 24, 2007
Summary
A new diagnostic strategy identified mutations in major deafness genes (GJB2, SLC26A4, mitochondrial 12S rRNA) in 29.6% of Japanese patients. The Invader assay offers a sensitive and accurate method for genetic screening of hearing loss.
Area of Science:
- Genetics
- Otolaryngology
- Molecular Biology
Background:
- Genetic heterogeneity of deafness hinders clinical application of gene identification.
- A need exists for efficient diagnostic strategies for hearing loss mutations.
Purpose of the Study:
- To design and validate a comprehensive diagnostic strategy for simultaneous detection of deafness gene mutations.
- To evaluate the efficacy of the Invader assay for screening known deafness-related mutations.
Main Methods:
- Developed a diagnostic strategy using a mutation/gene database and Invader assay screening.
- Screened 41 known mutations in nine deafness genes among 338 Japanese patients with congenital or childhood-onset bilateral sensorineural hearing loss.
Main Results:
- Identified mutations in GJB2, SLC26A4, and/or mitochondrial 12S rRNA in 100 (29.6%) subjects.
- These three genes represent the major causative factors for deafness in the studied Japanese population.
- The Invader assay demonstrated high sensitivity and accuracy in mutation detection.
Conclusions:
- The developed strategy effectively identifies major deafness gene mutations in Japanese patients.
- The Invader assay is a valuable tool for improving medical management and genetic counseling for hearing impairment.
- This approach facilitates efficient genetic screening for congenital and childhood-onset hearing loss.
